These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2422192)

  • 1. Enzyme-linked immunoassay of pre-S gene-coded sequences in hepatitis B vaccines.
    Neurath AR; Strick N; Kent SB; Offensperger W; Wahl S; Christman JK; Acs G
    J Virol Methods; 1985 Dec; 12(3-4):185-92. PubMed ID: 2422192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatitis B virus contains pre-S gene-encoded domains.
    Neurath AR; Kent SB; Strick N; Taylor P; Stevens CE
    Nature; 1985 May 9-15; 315(6015):154-6. PubMed ID: 2581144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antiviral antibodies with predetermined specificity using synthetic peptide--beta-lactamase conjugates: application to antibodies specific for the preS region of the hepatitis B virus envelope proteins.
    Neurath AR; Kent SB; Strick N
    J Gen Virol; 1986 Mar; 67 ( Pt 3)():453-61. PubMed ID: 2419488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic restriction of immune responsiveness to synthetic peptides corresponding to sequences in the pre-S region of the hepatitis B virus (HBV) envelope gene.
    Neurath AR; Kent SB; Strick N; Stark D; Sproul P
    J Med Virol; 1985 Oct; 17(2):119-25. PubMed ID: 4056755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Occurrence of pre-S1 antigen in viremic and nonviremic carriers of hepatitis B surface antigen.
    Budkowska A; Dubreuil P; Gerlich WH; Lazizi Y; Pillot J
    J Med Virol; 1988 Oct; 26(2):217-25. PubMed ID: 2460586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of monoclonal antibodies specific for the pre-S2 region of the hepatitis B virus envelope protein.
    Neurath AR; Adamowicz P; Kent SB; Riottot MM; Strick N; Parker K; Offensperger W; Petit MA; Wahl S; Budkowska A
    Mol Immunol; 1986 Sep; 23(9):991-7. PubMed ID: 2431299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunizations with chimeric hepatitis B virus-like particles to induce potential anti-hepatitis C virus neutralizing antibodies.
    Vietheer PT; Boo I; Drummer HE; Netter HJ
    Antivir Ther; 2007; 12(4):477-87. PubMed ID: 17668556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interactions of hepatitis B virus with hepatocytes: mechanism and clinical relevance.
    Theilmann L; Goeser T
    Hepatogastroenterology; 1991 Feb; 38(1):10-3. PubMed ID: 1709133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunochemical structure of the hepatitis B surface antigen vaccine--II. Analysis of antibody responses in human sera against the envelope proteins.
    Petit MA; Maillard P; Capel F; Pillot J
    Mol Immunol; 1986 May; 23(5):511-23. PubMed ID: 3748012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing.
    Neurath AR; Kent SB; Parker K; Prince AM; Strick N; Brotman B; Sproul P
    Vaccine; 1986 Mar; 4(1):35-7. PubMed ID: 2421497
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A virulent Salmonella expressing hybrid hepatitis B virus core/pre-S genes for oral vaccination.
    Schödel F; Peterson D; Hughes J; Milich DR
    Vaccine; 1993; 11(2):143-8. PubMed ID: 7679864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of protection level of anti-pre-S2 antibodies in humans immunized with a novel hepatitis B vaccine consisting of M (pre-S2 + S) protein particles (a third generation vaccine).
    Kuroda S; Fujisawa Y; Iino S; Akahane Y; Suzuki H
    Vaccine; 1991 Mar; 9(3):163-9. PubMed ID: 1828318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutralization effects of antibody elicited by chimeric HBV S antigen viral-like particles presenting HCV neutralization epitopes.
    Wei S; Lei Y; Yang J; Wang X; Shu F; Wei X; Lin F; Li B; Cui Y; Zhang H; Wei S
    Vaccine; 2018 Apr; 36(17):2273-2281. PubMed ID: 29576303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis B virus surface antigen (HBsAg) as carrier for synthetic peptides having an attached hydrophobic tail.
    Neurath AR; Strick N; Girard M
    Mol Immunol; 1989 Jan; 26(1):53-62. PubMed ID: 2467197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of antibodies to pre-S2 encoded epitopes of hepatitis B virus by monoclonal antibody-enzyme immunoassay.
    Budkowska A; Dubreuil P; Pillot J
    J Immunol Methods; 1987 Aug; 102(1):85-92. PubMed ID: 2442267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunogenicity of the gene S and Pre-S domains in hepatitis B virions and HBsAg filaments.
    Heermann KH; Kruse F; Seifer M; Gerlich WH
    Intervirology; 1987; 28(1):14-25. PubMed ID: 2448264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to hepatitis B virus proteins: relevance of the murine model.
    Milich DR
    Semin Liver Dis; 1991 May; 11(2):93-112. PubMed ID: 1832237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods for the study of pre-S proteins of hepatitis B virus and their antibodies: pathogenetic and clinical implications.
    Alberti A; Pontisso P; Milanesi G
    Ric Clin Lab; 1988; 18(2-3):241-58. PubMed ID: 3062749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-pre-S antibodies in different groups of patients with hepatitis B virus infection.
    Irshad M; Gandhi BM; Acharya SK; Joshi YK; Tandon BN
    J Gastroenterol Hepatol; 1989; 4(1):25-32. PubMed ID: 2490940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of pre-S gene-encoded proteins in liver and serum during chronic hepatitis B virus infection in comparison to other markers of active virus replication.
    Hadziyannis S; Raimondo G; Papaioannou C; Anastassakos C; Wong D; Sninsky J; Shafritz D
    J Hepatol; 1987 Dec; 5(3):253-9. PubMed ID: 3429833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.